Aditxt, Inc. Announces Appointment of Ernie Lee as CEO of its Wholly-Owned Subsidiary, Pearsanta, to Lead Launch of Test2Treat.me PlatformBusiness Wire • 10/05/23
Aditxt, Inc. (NASDAQ: ADTX) Announces Participation at the H.C. Wainwright 25th Annual Global Investment Conference September 11th-13th, 2023Business Wire • 09/08/23
Aditxt Announces Closing of $10.0 Million Private Placement Priced At-The-Market under Nasdaq RulesBusiness Wire • 09/06/23
Aditxt Announces $10.0 Million Private Placement Priced At-The-Market under Nasdaq RulesBusiness Wire • 08/31/23
Aditxt, Inc. (NASDAQ: ADTX) Provides Shareholder Update and Planned Strategy for Achieving Commercial ScaleBusiness Wire • 08/18/23
CORRECTING and REPLACING Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock Split Effective at the Open of Trading on August 18, 2023Business Wire • 08/17/23
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock Split Effective at the Open of Trading on August 18, 2023Business Wire • 08/17/23
Aditxt, Inc.'s Wholly-Owned Subsidiary Pearsanta, Inc. Looks to Expand Customer Base, Payor Access, and Genetic Testing with a Non-Binding Letter of Intent to Acquire Natural State Laboratories and Natural State GenomicsBusiness Wire • 06/20/23
Aditxt Subsidiary Adimune Signs Clinical Trial Agreement with Top Research Institution to Study Stiff Person SyndromeBusiness Wire • 05/05/23
Aditxt Announces Closing of $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesBusiness Wire • 04/24/23
Aditxt Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesBusiness Wire • 04/20/23
Aditxt Signs Asset Purchase Agreement to Acquire Fifty Percent Ownership of Global Response Aid – with Rights to Manufacture and Market Broad-Spectrum Antiviral Drug AviganBusiness Wire • 04/20/23
Aditxt Names Media Industry Veteran Maureen Connolly as Chief Content and Engagement OfficerBusiness Wire • 03/08/23
Aditxt Retains Riverside Management Group as Advisor to Support Strategic M&A Driven Acquisitions by Subsidiary Pearsanta, Inc.Business Wire • 03/03/23
Aditxt Forms its Second Subsidiary, Pearsanta, Inc., to Accelerate the Growth of its AditxtScore™ Program and Appoints Healthcare Executive and Current Head of AditxtScore™ Anthony Voorhies to Serve as its PresidentBusiness Wire • 02/14/23
Aditxt Forms Adimune, Inc. as a Wholly Owned Subsidiary with a Focus on Immune Modulation Therapies and Appoints Dr. Friedrich Kapp, Former President of the Therapeutic Business Unit at Schering AG, as its Chairman and CEOBusiness Wire • 01/03/23